Skip to main content
Multiple Sclerosis Discovery Forum
User Top Menu
Who We Are
How to Cite
News & Future Directions
Essays & Opinions
Meetings & Events
Clinical Trials - Public Availability of Results
MS trials baseline
Map of MS Prevalence
Progressive MS Authors Galaxy
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Scientific Literature TreeMap
Clinical Trials in MS
Click Here to Support MSDF
You are here
Most Viewed Papers
CEACAM1 mediates B cell aggregation in central nervous system autoimmunity.
Autoimmunity in 2015.
Barriers experienced by patients with multiple sclerosis in seeking care for lower urinary tract symptoms.
Cognitive motor interference in multiple sclerosis: Insights from a systematic, quantitative review.
HLA Genetic Risk Burden in Multiple Sclerosis.
Sunlight exposure: Do health benefits outweigh harm?
Cre inducible site-specific recombination in zebrafish oligodendrocytes.
Mortality in Hungarian patients with multiple sclerosis between 1993 and 2013.
Progress does not just come in giant leaps: adapting techniques for the study of inflammation to novel applications.
Sex differences and subclinical retinal injury in pediatric-onset MS.
Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case-control assessment of the vaccine adverse event reporting system (VAERS) database.
Exercise Effects on Early Vocal Ultrasonic Communication Dysfunction in a PINK1 Knockout Model of Parkinson's Disease.
Anti-MAG autoantibodies are increased in Parkinson's disease but not in atypical parkinsonism.